225 related articles for article (PubMed ID: 19800466)
1. Does magnetic resonance imaging accurately predict residual disease in breast cancer?
Stucky CC; McLaughlin SA; Dueck AC; Gray RJ; Giurescu ME; Carpenter SG; Grimsby GM; Apsey HA; Pockaj BA
Am J Surg; 2009 Oct; 198(4):547-52. PubMed ID: 19800466
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of the breast in evaluating residual diseases at lumpectomy site soon after excisional biopsy.
Yang H; Liu H; Peng W; Hua Y
J Comput Assist Tomogr; 2012; 36(2):196-9. PubMed ID: 22446359
[TBL] [Abstract][Full Text] [Related]
3. Postexcisional breast magnetic resonance imaging in patients with breast cancer: predictable findings of residual cancer.
Kim JA; Son EJ; Kim EK; Kim MJ; Kwak JY; Jeong J
J Comput Assist Tomogr; 2009; 33(6):940-5. PubMed ID: 19940664
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of breast MRI in predicting breast conservation therapy.
Blair S; McElroy M; Middleton MS; Comstock C; Wolfson T; Kamrava M; Wallace A; Mortimer J
J Surg Oncol; 2006 Sep; 94(3):220-5. PubMed ID: 16900536
[TBL] [Abstract][Full Text] [Related]
5. MRI-model to guide the surgical treatment in breast cancer patients after neoadjuvant chemotherapy.
Straver ME; Loo CE; Rutgers EJ; Oldenburg HS; Wesseling J; Vrancken Peeters MJ; Gilhuijs KG
Ann Surg; 2010 Apr; 251(4):701-7. PubMed ID: 20224378
[TBL] [Abstract][Full Text] [Related]
6. MRI before reexcision surgery in patients with breast cancer.
Lee JM; Orel SG; Czerniecki BJ; Solin LJ; Schnall MD
AJR Am J Roentgenol; 2004 Feb; 182(2):473-80. PubMed ID: 14736685
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation.
Al-Hallaq HA; Mell LK; Bradley JA; Chen LF; Ali AN; Weichselbaum RR; Newstead GM; Chmura SJ
Cancer; 2008 Nov; 113(9):2408-14. PubMed ID: 18823018
[TBL] [Abstract][Full Text] [Related]
8. Role of magnetic resonance imaging in the diagnosis of recurrence after breast conserving therapy.
Belli P; Pastore G; Romani M; Terribile D; Canadè A; Costantini M
Rays; 2002; 27(4):241-57. PubMed ID: 12696288
[TBL] [Abstract][Full Text] [Related]
9. Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer--clinical examination, mammography, or magnetic resonance imaging?
Wright FC; Zubovits J; Gardner S; Fitzgerald B; Clemons M; Quan ML; Causer P
J Surg Oncol; 2010 Jun; 101(7):604-10. PubMed ID: 20461768
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results.
Vincens E; Balleyguier C; Rey A; Uzan C; Zareski E; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
Cancer; 2008 Oct; 113(8):2158-65. PubMed ID: 18780318
[TBL] [Abstract][Full Text] [Related]
11. Predictors of surgical margin status in breast-conserving surgery within a breast screening program.
Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB
Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180
[TBL] [Abstract][Full Text] [Related]
12. Utility of breast MRI for evaluation of residual disease following excisional biopsy.
Wilkinson J; Appleton CM; Margenthaler JA
J Surg Res; 2011 Oct; 170(2):233-9. PubMed ID: 21550064
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers.
Bilimoria KY; Cambic A; Hansen NM; Bethke KP
Arch Surg; 2007 May; 142(5):441-5; discussion 445-7. PubMed ID: 17515485
[TBL] [Abstract][Full Text] [Related]
14. Is there concordance of invasive breast cancer pathologic tumor size with magnetic resonance imaging?
Grimsby GM; Gray R; Dueck A; Carpenter S; Stucky CC; Aspey H; Giurescu ME; Pockaj B
Am J Surg; 2009 Oct; 198(4):500-4. PubMed ID: 19800455
[TBL] [Abstract][Full Text] [Related]
15. Presence of extensive intraductal component in patients undergoing breast conservative surgery predicts presence of residual disease in subsequent completion mastectomy.
Yiu CC; Loo WT; Lam CK; Chow LW
Chin Med J (Engl); 2009 Apr; 122(8):900-5. PubMed ID: 19493411
[TBL] [Abstract][Full Text] [Related]
16. The impact of MRI on the treatment of DCIS.
Chung A; Saouaf R; Scharre K; Phillips E
Am Surg; 2005 Sep; 71(9):705-10. PubMed ID: 16468502
[TBL] [Abstract][Full Text] [Related]
17. Predictors of re-excision for positive or close margins in breast-conservation therapy for pT1 tumors.
Ramanah R; Pivot X; Sautiere JL; Maillet R; Riethmuller D
Am J Surg; 2008 Jun; 195(6):770-4. PubMed ID: 18394582
[TBL] [Abstract][Full Text] [Related]
18. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.
Buchanan CL; Morris EA; Dorn PL; Borgen PI; Van Zee KJ
Ann Surg Oncol; 2005 Dec; 12(12):1045-53. PubMed ID: 16244803
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced breast magnetic resonance imaging: the surgical perspective.
Beatty JD; Porter BA
Am J Surg; 2007 May; 193(5):600-5; discussion 605. PubMed ID: 17434364
[TBL] [Abstract][Full Text] [Related]
20. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging.
Frei KA; Kinkel K; Bonel HM; Lu Y; Esserman LJ; Hylton NM
AJR Am J Roentgenol; 2000 Dec; 175(6):1577-84. PubMed ID: 11090379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
